Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival

Ying Zhang,Yajie Ji,Jianwei Li,Li Lei,Siyu Wu,Wenjia Zuo,Xiaoqing Jia,Yujie Wang,Miao Mo,Na Zhang,Zhenzhou Shen,Jiong Wu,Zhimin Shao,Guangyu Liu

Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival

2018

Ying Zhang
Yajie Ji
Jianwei Li
Li Lei
Siyu Wu
Wenjia Zuo
Xiaoqing Jia
Yujie Wang
Miao Mo
Na Zhang
Zhenzhou Shen
Jiong Wu
Zhimin Shao
Guangyu Liu

Objective To investigate ovarian function and therapeutic efficacy among estrogen receptor (ER)-positive, premenopausal breast cancer patients treated with gonadotropin-releasing hormone agonist (GnRHa) and chemotherapy simultaneously or sequentially.

Keywords:

Breast cancer
Hormone
Endocrinology
Gonadotropin-releasing hormone agonist
Premenopausal breast cancer
Estrogen receptor
Disease
Internal medicine
Agonist
Medicine
Chemotherapy
ovarian function
Cancer research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations